About
Dr. Barak’s career has focused on the integration of clinical medicine, basic research, and pharmaceutical development. He served as an attending physician in the department of internal medicine at Beilinson Hospital for 10 years. Dr. Barak began engaging in drug development driven by feedback received from patients regarding shortcomings in available treatment options. Nir served as CSO and Founder of Obscure Ltd. — a company focused on re-purposing Betahistine as an anti-obesity agent. In 2008 after learning from patients of the dearth of treatment options for anorectal diseases, he founded RDD Pharma. Under Nir’s leadership, RDD has attracted significant investment from OrbiMed Advisors. — a multinational private equity fund. Dr. Barak earned his MD from the Sackler School of Medicine, Tel-Aviv University, and is Board Certified in Internal Medicine and Clinical Nutrition.
Investment Focus
- Location
- Ramat Gan, Israel
Contact Information
Find more investors like Nir
Search Investors